Market Report - Europe Close
A bounce in European stocks had largely petered out by the end of trading on Tuesday despite the stiff losses sustained over the preceding three sessions and hampered by a small tightening of Covid-19 restrictions in the UK and PMI readings in the Eurozone area showing stalling demand.
European stocks finished the Tuesday session on a mixed note despite the sell-off endured over the previous three sessions with French and Spanish shares weaker due to concerns around the still quickly rising number of Covid-19 infections in both.
European shares started the week deep in the red as fears over increasing coronavirus cases across the Continent combined with a leak of confidential reports from banks around the world to the US Treasury regarding potential money laundering to knock investor sentiment hard.
European shares were lower at the end of the week with travel stocks acting as the main drag amid concern over tightening mobility restrictions including in the UK and Spain and a fast rising case count in France.
European shares finished weaker on Thursday but well off their intraday lows as investors digested more dovish than expected remarks from central banks around the world, not least from the US Federal Reserve overnight.
European shares recovered from a late bout of selling on Wednesday to finish in the green.
European stocks clocked in with slight gains buoyed by advances among retailers after Sweden's Hennes&Mauritz blew past analysts' forecasts and helped by an upbeat reading on economic confidence out of Germany.
European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
Stocks in Europe headed into the weekend little changed despite the multitude of political concerns weighing on investor sentiment, ranging from the upcoming US presidential elections, through to Brexit and US-China relations.
Stocks across the Continent finished the session slightly lower as early gains on Wall Street reversed and amid heightened volatility in currency markets.
Stocks in Europe finished higher tracking a bounce on Wall Street with investors shrugging off news that AstraZeneca has paused the phase three clinical trials of its leading Covid-19 vaccine candidate.
European shares finished sharply lower amid continued heaving selling in tech stocks and more concerns about Britain's belligerent stance on Brexit trade talks.
European shares powered ahead at midday as they bounced back from last week’s US tech-stock sell-off and ignored threats the UK would walk away from Brexit trade talks without a deal.
Stocks across the Continent finished the week on a down note going into the long Labor Day holiday Stateside, weighed down by a renewed bout of selling on Wall Street.
A slightly worse than expected reading on weekly US jobs filings triggered profit-taking took stocks in Europe down a peg.
Stocks across the Continent bounded higher on Wednesday, tracking fresh gains overnight on Wall Street and helped by a dip in the single currency's value.
Stocks in Europe finished on a mixed note despite upbeat manufacturing sector figures out of Germany and Chinese survey data showing the quickest pace of growth since 2011.
European markets finished the week on a down note as the single currency continued gaining altitude with disappointing data from France and Germany pulling the Continent’s benchmark indices lower.
Stocks in Europe fell as investors booked profits after the head of the US central bank confirmed, as had been widely anticipated, that monetary policy would remain easier for longer.
Stocks in Europe clocked in with sharp gains, finishing the day at their session highs and in the case of some benchmarks at their best levels in several months.